News
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays.
Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler; CFC-free. Store at room temperature between 68° F and 77° F (20° C and ...
GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business. The FDA approved ...
Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...
Hosted on MSN1mon
OptumRX responds to Wisconsin family’s lawsuit for asthma deathNOTE: This story has been updated with a statement from the family, which is featured at the bottom of the article. GREEN BAY, Wis. (WBAY) - One of the companies being sued by the family of an ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates, clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results